What they were paid
X4 Pharmaceuticals Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $41,861 | $6,210 | — | $0 | $48,071 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: X4 Pharmaceuticals, Inc DEF 14A filed March 20, 2026, accession 0001501697-26-000031, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025X4 Pharmaceuticals pays directors a $40,000 cash retainer.
The rest of the X4 Pharmaceuticals board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Adam R. Craig, M.D., Ph.D., M.B.A | Chair of the Board | $0 |
| Françoise De Craecker | Independent Director | $57,101 |
| Gary J. Bridger, Ph.D | Independent Director | $64,770 |
| Michael S. Wyzga | Lead Independent Director | $89,147 |
| Murray W. Stewart, M.D | Independent Director | $62,710 |
The full X4 Pharmaceuticals compensation record
free company briefThis page is one director within X4 Pharmaceuticals's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat